Article info
Small intestine
Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea
- Dr M Camilleri, Mayo Clinic, Gastroenterology Unit—Alfred 2–435, 200 First St SW, Rochester, Minnesota 55905, USA.
Citation
Medium term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea
Publication history
- Accepted December 18, 1997
- First published May 1, 1998.
Online issue publication
February 14, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
British Society of Gastroenterology